Journal Browser
Volume | Year
News and Announcements
View All

Bioprinting Tissues for Disease Modeling, Drug Development and Drug Testing

Submission deadline: 30 June 2023
Special Issue Editors
David K. Mills
School of Biological Sciences, Louisiana Tech University, Ruston, Los Angeles, United States
Interests: Biological Sciences; Drug delivery; Halloysite Nanotube; 3D printing and bioprinting; Implant design and functionalization
Special Issue Information

3D bioprinting is a relatively novel tissue engineering strategy; it holds great potential to play a critical role in personalized medicine. Recent advances in 3D bioprinting have significantly advanced the field of disease modeling, drug development, and development and therapeutic screening. In addition, tissue arrays can be used to study cellular metabolism and physiology. Bioprinting generally is based on a few main technological approaches such as extrusion, inkjet, laser-assisted, or stereolithography.

This special issue will focus on advances in 3D bioprinting, emphasizing applications directed towards specific diseases and disorders tissue for drug development and testing. Specifically, papers address medical applications of 3D bioprinted biomaterials and technologies and high throughput 3D models to improve disease modeling, drug efficacy testing, and precision medical applications. Additionally, papers on 3D printed biomaterials in clinical applications, the state-of-the-art developments in drug formulation, the commercial development of materials, tools, their applications, and legal and regulatory hurdles are most welcome.

disease modeling
drug development
drug testing
medical applications
tissue models
Published Paper (2 Papers)

Organoid bioprinting strategy and application in biomedicine: A review

Chen He, Jiasheng Yan, Yusheng Fu, Jiuchuan Guo, ... Jinhong Guo
Back to top
International Journal of Bioprinting, Electronic ISSN: 2424-8002 Print ISSN: 2424-7723, Published by AccScience Publishing